Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Molecular Biomarkers of Anaplastic Thyroid Carcinoma Publisher Pubmed



Bozorgghalati F1, 2 ; Hedayati M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Current Molecular Medicine Published:2017


Abstract

Anaplastic thyroid carcinoma is the rarest but extremely aggressive thyroid cancer subtype. This neoplasia is composed of undifferentiated tumor cells with poor prognosis and resistant to common thyroid cancer therapy. Early stage identification of this cancer for prompt treatment is very vital. Presently, cytological evaluation of fine needle aspiration biopsy (FNAB) which is known as invasive recognition assay, is the standard diagnostic method for the diagnosis of malignant thyroid tumors. Frequent studies have suggested that using the molecular biomarkers of thyroid cancer tissue alongside cytological examination, increase the accuracy of diagnostic tests. Also, these agents could be beneficial for effective target therapy and personalize medicine. In this review, the molecular biomarkers that are involved in anaplastic thyroid carcinoma in four category (gene mutation profile, epigenetic profile, microRNA profile and cancer stem cell markers) were summarized. © 2017 Bentham Science Publishers.
Related Docs
View other Related Docs
1. The Role of Micrornas in Different Types of Thyroid Carcinoma: A Comprehensive Analysis to Find New Mirna Supplementary Therapies, Journal of Endocrinological Investigation (2018)
2. Meta-Analysis of Promoter Methylation in Eight Tumor-Suppressor Genes and Its Association With the Risk of Thyroid Cancer, PLoS ONE (2017)
3. Targeting the Braf Signaling Pathway in Cd133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma, Asian Pacific Journal of Cancer Prevention (2019)
4. A Review on the Molecular Pathology of Epithelial Thyroid Tumors, Journal of Isfahan Medical School (2018)
5. The Role of Atp-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review, Endocrinology (2019)
6. Pi3k/Akt Pathway and Its Mediators in Thyroid Carcinomas, Molecular Diagnosis and Therapy (2016)
7. Bi-847325, a Selective Dual Mek and Aurora Kinases Inhibitor, Reduces Aggressive Behavior of Anaplastic Thyroid Carcinoma on an in Vitro Three-Dimensional Culture, Cancer Cell International (2022)
8. Cancer Genetics at a Glance: The Comprehensive Insights, Cancer Genetics and Psychotherapy (2017)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (8)
Seyed Mohammad Tavangar (6)
Other Related Docs
9. Hypermethylated Rassf1 and Slc5a8 Promoters Alongside Brafv600e Mutation As Biomarkers for Papillary Thyroid Carcinoma, Journal of Cellular Physiology (2020)
10. Cancer Stem-Like Cell Behavior in Anaplastic Thyroid Cancer: A Challenging Dilemma, Life Sciences (2016)
11. Personalized Treatment Options for Thyroid Cancer: Current Perspectives, Pharmacogenomics and Personalized Medicine (2019)
12. Genetic and Epigenetic of Medullary Thyroid Cancer, Iranian Biomedical Journal (2018)
13. Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling Pathways, Acta Medica Iranica (2017)
14. Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma, Iranian Journal of Pathology (2019)
15. The Epigenetic Modification of Slc5a8 in Papillary Thyroid Carcinoma and Its Effects on Clinic-Pathological Features, Iranian Journal of Public Health (2022)
16. Assessment of Axl and Mtor Genes Expression in Medullary Thyroid Carcinoma (Mtc) Cell Line in Relation With Over Expression of Mir-144 and Mir-34A, Hormone Molecular Biology and Clinical Investigation (2021)
17. Molecular Mechanisms of Long Non-Coding Rnas in Anaplastic Thyroid Cancer: A Systematic Review, Cancer Cell International (2020)
18. Liquid Biopsy As a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations, International Journal of Molecular and Cellular Medicine (2019)